Nuvalent, Inc. (NUVL)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$123.960.00%
Close 2026-07-16 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · NUVL
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | |
|---|---|---|---|---|---|---|---|
| Operating Expenses & Income | |||||||
| R&D Expenses | 316.2 | 307.0 | 217.8 | 113.2 | 63.7 | 35.6 | 15.4 |
| Operating Income | (438.9) | (414.3) | (280.4) | (149.5) | (86.1) | (45.8) | (16.9) |
| Earnings from Continuing Operations | |||||||
| Interest & Investment Income | 45.8 | 44.8 | 38.4 | 23.3 | 4.3 | — | — |
| Other Non-Operating Income / Expenses | (10.6) | (10.5) | 20.4 | 23.3 | 4.3 | (0.5) | 2.3 |
| EBT, Incl. Unusual Items | (449.5) | (424.8) | (260.0) | (126.2) | (81.9) | — | — |
| Income Tax Expense | 0.6 | 0.6 | 0.8 | 0.0 | 0.0 | — | — |
| Net Income | |||||||
| Net Income | (450.1) | (425.4) | (260.8) | (126.2) | (81.9) | (46.3) | (14.6) |
| Per Share | |||||||
| Basic EPS | (5.72) | (5.85) | (3.93) | (2.17) | (1.65) | (2.13) | (5.08) |
| Diluted EPS | (5.72) | (5.85) | (3.93) | (2.17) | (1.65) | (2.13) | (5.08) |
| Basic Weighted Avg Shares | 78.7 | 72.7 | 66.4 | 58.2 | 49.7 | 21.8 | 2.9 |
| Diluted Weighted Avg Shares | 78.7 | 72.7 | 66.4 | 58.2 | 49.7 | 21.8 | 2.9 |
| Supplemental | |||||||
| EBIT | (438.9) | (414.3) | (280.4) | (149.5) | (86.1) | (45.8) | (16.9) |
| Effective Tax Rate | -0.1% | — | — | 0.0% | 0.0% | — | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.